Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

This program funds integrated studies that combine imaging and liquid biopsy monitoring in cancer treatment to measure response, failure, recurrence, and resistance. Eligible applicants include a wide range of U.S. organizations, including nonprofits, schools, governments, small businesses, and for-profit organizations; foreign organizations and non-U.S. components of U.S. organizations are not eligible, though foreign components are allowed. Awards are for new or resubmission applications, with budgets limited to less than $500,000 in direct costs per year and project periods up to 5 years. No cost sharing is required.

✳ AI-generated summary — verify against the announcement

• Education
• Health
• Research & Discovery
• Patients & People with Health Conditions
• Biomedical & Disease Research

• ✓ City or township governments
• ✓ County governments
• ✓ For-profit organizations other than small businesses
• ✓ Independent school districts
• ✓ Native American tribal governments (Federally recognized)
• ✓ Native American tribal organizations (other than Federally recognized)
• ✓ Nonprofits with 501(c)(3) status (other than higher education)
• ✓ Nonprofits without 501(c)(3) status (other than higher education)
• ✓ Others
• ✓ Private institutions of higher education
• ✓ Public and State controlled institutions of higher education
• ✓ Public housing authorities / Indian housing authorities
• ✓ Small businesses
• ✓ Special district governments
• ✓ State governments